Christopher Dye
Christopher Dye
Dirección de correo verificada de zoo.ox.ac.uk - Página principal
Título
Citado por
Citado por
Año
Global Tuberculosis Control
WH Organization
23079*2007
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic
EL Corbett, CJ Watt, N Walker, D Maher, BG Williams, MC Raviglione, ...
Archives of internal medicine 163 (9), 1009-1021, 2003
37492003
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.
C Dye, S Scheele, P Dolin, V Pathania, MC Raviglione
Jama 282 (7), 677-686, 1999
27911999
Disease control priorities in developing countries
DT Jamison, JG Breman, AR Measham, G Alleyne, M Claeson, DB Evans, ...
The World Bank, 2006
26632006
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
RM Granich, CF Gilks, C Dye, KM De Cock, BG Williams
The Lancet 373 (9657), 48-57, 2009
22152009
Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country
C Dye, S Scheele, V Pathania, MC Raviglione
Jama 282 (7), 677-686, 1999
18081999
Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections
WHO Ebola Response Team
New England Journal of Medicine 371 (16), 1481-1495, 2014
15192014
Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
BB Trunz, PEM Fine, C Dye
The Lancet 367 (9517), 1173-1180, 2006
11022006
Estimates of world-wide distribution of child deaths from acute respiratory infections
BG Williams, E Gouws, C Boschi-Pinto, J Bryce, C Dye
The Lancet infectious diseases 2 (1), 25-32, 2002
10762002
Heterogeneities in the transmission of infectious agents: implications for the design of control programs
MEJ Woolhouse, C Dye, JF Etard, T Smith, JD Charlwood, GP Garnett, ...
Proceedings of the National Academy of Sciences 94 (1), 338-342, 1997
10241997
Global epidemiology of tuberculosis
C Dye
The Lancet 367 (9514), 938-940, 2006
10122006
Global trends in resistance to antituberculosis drugs
MA Espinal, A Laszlo, L Simonsen, F Boulahbal, SJ Kim, A Reniero, ...
New England Journal of Medicine 344 (17), 1294-1303, 2001
10022001
Drivers of tuberculosis epidemics: the role of risk factors and social determinants
K Lönnroth, E Jaramillo, BG Williams, C Dye, M Raviglione
Social science & medicine 68 (12), 2240-2246, 2009
10002009
The effect of human mobility and control measures on the COVID-19 epidemic in China
MUG Kraemer, CH Yang, B Gutierrez, CH Wu, B Klein, DM Pigott, ...
Science 368 (6490), 493-497, 2020
8832020
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries
MA Espinal, SJ Kim, PG Suarez, KM Kam, AG Khomenko, GB Migliori, ...
Jama 283 (19), 2537-2545, 2000
8602000
Global incidence of multidrug-resistant tuberculosis
M Zignol, MS Hosseini, A Wright, CL Weezenbeek, P Nunn, CJ Watt, ...
The Journal of infectious diseases 194 (4), 479-485, 2006
7772006
An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China
H Tian, Y Liu, Y Li, CH Wu, B Chen, MUG Kraemer, B Li, J Cai, B Xu, ...
Science 368 (6491), 638-642, 2020
7132020
Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally
C Dye, CJ Watt, DM Bleed, SM Hosseini, MC Raviglione
Jama 293 (22), 2767-2775, 2005
7002005
The population dynamics and control of tuberculosis
C Dye, BG Williams
Science 328 (5980), 856-861, 2010
6942010
Prospects for worldwide tuberculosis control under the WHO DOTS strategy
C Dye, GP Garnett, K Sleeman, BG Williams
The Lancet 352 (9144), 1886-1891, 1998
6291998
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20